Giovanni Di Vagno - Concepedia

Author

Giovanni Di Vagno

University of Bari Aldo Moro

Also Known As

G Di Vagno, G di Vagno, G. Di Vagno, G. di Vagno, G.D.I. Vagno, GIOVANNI DI VAGNO, Giovanni Di Vagno, Giovanni di Vagno

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University of Bari Aldo Moro Istituti di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"Università Cattolica del Sacro Cuore Istituto Tumori Bari

About

Giovanni Di Vagno is an author at University of Bari Aldo Moro specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	459
2	Public Health	3	3	60
3	Epidemiology	2	2	42
4	Nursing	1	1	12
5	Family Medicine	1	1	12

Giovanni Di Vagno

Publications

906

Citations

H-Index

Page 1

	Year	Citations
Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno, Journal of Clinical Oncology	2004	164
Conservative treatment of early endometrial cancer: Preliminary results of a pilot study Giuseppe Laurelli, Giovanni Di Vagno, Cono Scaffa, Gynecologic Oncology Gynecological SurgeryEarly Endometrial CancerMedicineGynecologyConservative Treatment	2010	125
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study Sandro Pignata, Sabino De Placido, R. Biamonte, BMC Cancer	2006	115
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients Domenica Lorusso, Gabriella Ferrandina, Stefano Greggi, Annals of Oncology Phase Iii MulticenterMedicineMetronomic TherapyPharmacologyClinical Trials	2003	94
Phase II Study of Cisplatin and Vinorelbine as First-Line Chemotherapy in Patients With Carcinoma of the Uterine Cervix Sandro Pignata, Giustino Silvestro, Ettore Ferrari, Journal of Clinical Oncology	1999	72
Lactobacillus crispatus M247 oral administration: Is it really an effective strategy in the management of papillomavirus-infected women? Miriam Dellino, Eliano Cascardi, Antonio Simone Laganà, Infectious Agents and Cancer	2022	63
Gynecological Malignancies in Elderly Patients: Is Age 70 a Limit to Standard-Dose Chemotherapy? An Italian Retrospective Toxicity Multicentric Study Marcello Ceccaroni, Giuseppe Roberto D’Agostino, Gabriella Ferrandina, Gynecologic Oncology Geriatric OncologyOncologyElderly PatientsGeriatricsAge 70	2002	46
SARS-CoV-2 Vaccines and Adverse Effects in Gynecology and Obstetrics: The First Italian Retrospective Study Miriam Dellino, Bruno Lamanna, Marina Vinciguerra, International Journal of Environmental Research and Public Health VaccinationVaccine SafetyItalian Medicine AgencyMaternal ImmunizationSars-cov-2 Vaccines	2022	30
A retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer A. Cristina Rossi, Giovanni Di Vagno, Gennaro Cormio, Archives of Gynecology and Obstetrics Retrospective StudyPreoperative Ca 125Gynecological SurgeryMedicineCancer Management	2004	23
Ovarian Carcinoma Metastatic to the Breast Gennaro Cormio, Giovanni Di Vagno, G A Melilli, Gynecologic and Obstetric Investigation Surgical OncologyBreast OncologyMedicineGynecologyPathology	2001	19

Page 1